SatishKGargMD
Endocrinology • Aurora, COProfessor, Pediatrics, University of Colorado School of Medicine
Are you Dr. Garg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1775 Aurora Ct
Aurora, CO 80045Phone+1 720-724-2323
Summary
- Dr. Satish Garg, MD is an endocrinologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado. He is affiliated with University of Colorado Hospital and Children's Hospital Colorado.
Education & Training
Christian Medical College VelloreClass of 1975
Certifications & Licensure
CO State Medical License 1992 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance Software Start of enrollment: 2005 Jul 01
- Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus Start of enrollment: 2009 Jul 01
- Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD.Vikas S Sridhar, Ayodele Odutayo, Satish Garg, Thomas Danne, Alessandro Doria
Journal of the American Society of Nephrology. 2024-11-01 - Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis.Satish K Garg, Irl B Hirsch, Enrico Repetto, Janet Snell-Bergeon, Brian Ulmer
Diabetes, Obesity & Metabolism. 2024-11-01 - 2 citationsBeta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin.Schafer Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard
Diabetes Technology & Therapeutics. 2024-09-01
Press Mentions
Continuous Glucose Monitors for All? Opinions Remain MixedNovember 12th, 2024- CGM Cuts Hospitalization in T2D, Even in Non-Insulin TreatedSeptember 18th, 2024
- CGM Cuts Hospitalization in T2D, Even in Non-Insulin TreatedSeptember 18th, 2024
- Join now to see all
Professional Memberships
- Member
Other Languages
- Hindi, Punjabi, Urdu
